Role of enzyme in tumour immune microenvironment identified
Researchers have found that reducing glycosylation on the T cell surface may offer new approaches to cancer immunotherapy.
List view / Grid view
Researchers have found that reducing glycosylation on the T cell surface may offer new approaches to cancer immunotherapy.
Researchers have discovered a molecule that binds to a cancer cell protein, stopping growth of breast and ovarian tumours.
An epitope on CD95 receptor causes tumour cells to self-destruct and may prolong benefits of CAR T-cell therapy for solid tumours.
Lactate producing bacteria is responsible for rewiring metabolic signalling pathways, causing resistance to radiation therapy.
Extracellular vesicles loaded with mRNA encoding interferon-gamma offers promise for treating difficult tumours.
3D tumour models enable scientists to offer better treatments and improve survival outcomes for complex conditions like breast cancer.
Bacteria programmed to paint targets on solid tumours for T cells to see eliminates the need for specific antigens.
A recent scientific collaboration, led by the Institute of Nuclear Physics of the Polish Academy of Sciences, has overcome measurement challenges, enabling reliable cancer diagnosis.
Research into how the amino acid arginine drives metabolic reprogramming offers promise for liver cancer treatment.
Midbody’s role in cell signalling and stimulating cell proliferation offers an opportunity to detect cancer.
A novel treatment approach using DON molecule starves tumours of essential nutrient, significantly slowing tumour growth.
Thousands of breast cancer gene expression signatures analysed.
New open-source computational method called Spectra improves analysis of single-cell transcriptomic data.